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The question of how the neural and immune systems interact in host defense is important,
integrating a system that senses the whole body with one that protects. Understanding
the mechanisms and routes of control could produce novel and powerful ways of
promoting and enhancing normal functions as well as preventing or treating abnormal
functions. Fragmentation of biological research into specialities has resulted in some
failures in recognizing and understanding interactions across different systems and this
is most striking across immunology, hematology, and neuroscience. This reductionist
approach does not allow understanding of the in vivo orchestrated response generated
through integration of all systems. However, many factors make the understanding of
multisystem cross-talk in response to a threat difficult, for instance the nervous and
immune systems share communication molecules and receptors for a wide range of
physiological signals. But, it is clear that physical, hard-wired connections exist between
the two systems, with the key link involving sensory, unmyelinated nerve fibers (c
fibers) containing the neuropeptide calcitonin gene-related peptide (CGRP), and modified
macrophages, mast cells and other immune and host defense cells in various locations
throughout the body. In this review we will therefore focus on the induction of CGRP and
its key role in the neuroimmune axis.
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SENSORY NEUROTRANSMITTER CGRP
Sensory neurotransmitters have been extensively studied and
their ability to affect different body functions has been shown
in a range of studies. One of the main sensory neurotransmitters
involved in immune function is CGRP. CGRP exemplifies a neu-
roimmune connector, since it is released at the site of stimulation,
affecting immediate responses as well as mediating information
flow to the rest of the nervous system. CGRP is a critical, highly
expressed sensory signal, making it an important member of
neuro-immune communication pathways. C fibers, the smallest
diameter unmyelinated sensory neurons, are the main source of
this neuropeptide. Their small diameter generates one of the low-
est threshold response elements in the nervous system indicating
their vital role. To date, this low threshold has placed them in the
category of nociceptive neurons as they are the first to register
damage/toxins through the pain pathway. This categorization is
reinforced by the fact that c fibers express on their surface the
transient receptor potential vanilloid 1 (TRPV1) which is a key
responder to tissue damage. However, below the pain threshold,
C fibers are likely to be playing a critical role in physiological
systems and in particular, in host monitoring and activation of
host defense and immune responses due to their low activation
potential.
CGRP RELEASE IN VIVO
CGRP is released in response to activation of TRPV1 in both
the nervous and immune systems. In the nervous system, TRPV1
is expressed along the entire length of the sensory c fiber neu-
rons, from the periphery to the somata in the CNS (Szallasi,
1995). These neurons innervate every organ and tissue in the
body (Buck and Burks, 1986; Holzer, 1991; Szallasi and Blumberg,
1999). Although a key exogenous ligand for TRPV1 is cap-
saicin, TRPV1 is also activated by a range of other endoge-
nous agonists including heat (>43◦C) (Caterina et al., 1997;
Tominaga et al., 1998), protons (∼pH 4.5) (Vyklicky et al.,
1998; Jordt et al., 2000), lipids like anandamide (Olah et al.,
2001), phosphatidylinositol(4,5)-biphosphate (PIP2) (Chuang
et al., 2001), and voltage (Gunthorpe et al., 2000) (summa-
rized in Figure 1). Heat and low pH activate TRPV1 by distinct
molecular recognition sites (Jordt et al., 2000). Additionally,
TRPV1 has been suggested to be a mechanosensitive receptor
in mediating nociceptive signals; for example TRPV1 deficient
mice exhibit reduced sensitivity to post colorectal distension
compared to controls (Jones et al., 2005) adding an interesting
physiological element to TRPV1 activation. In rats, sensory vanil-
loid receptor-bearing nerves are classed as peptidergic and/or
purinergic (Guo et al., 1999). Peptidergic nerves express TRPV1
and co-express neuropeptides whilst purinergic nerves express
TRPV1 and co-express an adenosine triphosphate (ATP) gated
ion-channel known as P2X3 (Yiangou et al., 2001).
Besides the well documented role of TRPV1 in the nervous sys-
tem, we now know that it is also expressed on immune cells, which
has direct relevance to this review. Absence of TRPV1 signal-
ing has been shown variously to exacerbate inflammation (Massa
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Macrophages
1. Inhibits mast cell degranulation
(Feng et al, 2010).
2. Majority of mast cells are
found ‘juxaposed’ with CGRP
containing nerve fibres during
N. brasiliensis infection(Lee et
al, 2013)
3. Involved through c fibres in
histamine release from mast
cells (Dimitriadou et al, 1994)
1. In the absence of antigen-
presentation, CGRP facilitates the
breaking of the T helper cell
commitment (Levite, 1998)
2. Regulation of T cell motility and
migration (Levite et al, 2000).
3. Upregulates IL9 and IL17 in asthma
and EAE (Mikami et al, 2012,13).
4. Increases CD4+CD25+Foxp3+ T
cells differentiation (Matsuda,
2012).
5. Affects early B cell differentiation
(Bracci-Laudero et al, 2002).
6. CGRP inhibits the expression of
surface immunoglobulin post LPS
(McGillis et al, 1995).
~PH 4.5
Anandamide
T/B lymphocytes
Mast cells 1. CGRP regulates MHCII &CD86
expression on human monocytes
(Bracci-Laudiero et al, 2005).
2. Regulates IL10 in bone derived and
peritoneal macrophages (Jusek et al,
2012).
3. Regulates the expression of CD11b
post LPS treatment (Monneret et al,
2003).
4. Promotes anti-inflammatory cytokine &
receptor expression post LPS
(Monneret et al, 2003).
5. Regulates TERM-1 production (Li et
al, 2010).
6. Regulates TNFα (Altmayr et al, 2010;
Gomes et al, 2005).
Dendritic cells
1. CGRP Inhibits HIV transfer
to T cells in vitro (Ganor et
al, 2013)).
2. Inhibits migration of DC to
local lymph nodes in contact
hypersensitivity models
(Mikami et al, 2011).
3. Promotes Th2 immunity
(Mikami et al, 2011)
4. Inhibits DC maturation,
motility and phagocytosis in
the lung (Voedisch et al,
2012)
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Low pH
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Membrane potential changes
Physical damage
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FIGURE 1 | Pathways of CGRP release via TRPV1 activation. TRPV1 is
activated by many external factors associated with pain but also regular
sensation below pain thresholds. These include the well characterized
responses to heat, pH, and damage, as well as to toxins, immune challenges
and membrane potential changes brought about by physiological and
pathological processes. Endogenous and/or intracellular activation can also
occur through the actions of PIP2 and Anandomide. Any activation of TRPV1
results in release of CGRP from the neuron. This released CGRP then acts on its
specific receptor on cells immediately adjacent to the neuron, which in the case
of sensory c fibers can be lymphocytes, DCs, mast cells, macrophages or cells
within the hemopoietic microenvironment of the bone marrow (not shown).
The range of activities stimulated by CGRP are listed below each cell type.
et al., 2006; Huang et al., 2009) and these effects can be attributed
indirectly to the subsequent lack of CGRP. Similarly, agonism
of TRPV1 with capsaicin has been shown to inhibit differentia-
tion and cytokine secretion of human dendritic cells (Toth et al.,
2009), thereby reducing early activation signals on challenge.
There are two isoforms of CGRP known: αCGRP and
βCGRP. αCGRP has been shown to be a potent vasodilator
and exhibits marked synergism with inflammatory mediators to
induce local edema (Bernard and Shih, 1990). αCGRP’s recep-
tors are found on mouse bone marrow cells, providing strong
evidence toward an eminent effect for αCGRP in modulating
immune cell function and differentiation which in turn may
affect the inflammatory cascade in response to a pathological
threat (Mullins et al., 1993). αCGRP has also been identified
as the predominant isotype in sensory neurons in the dor-
sal root ganglion (DRG) (Gibson et al., 1988). Unless stated
otherwise, the observations discussed below refer to αCGRP
only.
PHYSIOLOGICAL ROLE FOR CGRP
CGRP was first described as a vasodilator nearly 30 years ago
(Brain et al., 1985). It is now well-established that CGRP regu-
lates blood pressure (Brain and Grant, 2004), is associated with
the onset of migraines when at high levels (Olesen, 2011a,b),
promotes the maintenance of mucosal integrity in the gastro-
intestinal tract (GIT) (Szolcsanyi and Bartho, 2001), aids stem cell
growth and maintenance in vitro (Dong et al., 2010) and modu-
lates keratinocyte growth (Roggenkamp et al., 2013). CGRP plays
a role in facilitating the absorption of intraluminal amino acids
across the distal parts of the intestines (Mourad et al., 2009). In
the lungs and elsewhere, CGRP promotes wound healing (Zhou
et al., 2013). In the stomach, gastric acid stimulates the release of
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CGRP via activation of local afferent neurons. CGRP itself orches-
trates the secretion of chemical factors that inhibit gastric acid
secretion and induce muscle repair (Aihara et al., 2005, 2006).
Furthermore, CGRP and other neuropeptide containing nerve
fibers extend all the way to the epithelial cell lining of the gut, sug-
gesting a role inmonitoring of the external (gut) environment. An
association with immune cells present in gut epithelium also sug-
gests an important role in the immune responses generated there
(Engel et al., 2010, 2011).
CGRP AND IMMUNITY
CGRP is the main neurotransmitter of the nociceptive sensory c
fibers, but is also present in other sensory nerve fibers i.e., type
A and B medium-sized neurons. CGRP is released when these
nerves are activated by specific agonists of TRPV1 usually during
trauma or injury and therefore additionally associated with pain
perception. However, c fibers have also been implicated in non-
nociceptive activities includingmodulation of immune responses,
through neuropeptide release (Beresford et al., 2004; Shepherd
et al., 2005a,b). In fact CGRP is abundant in many immune
organs. Nerve fibers containing CGRP have been identified in
bone marrow, thymus, spleen, lymph nodes, skin, lungs, and
gut and CGRP receptors are found on many hematopoietic cell
types (Santambrogio et al., 1993; Petitto et al., 1994; Mach et al.,
2002). In the bonemarrow, these fibers accompany noradrenergic
sympathetic fibers and are distributed throughout the marrow.
The role of sensory neurotransmitters in the hematopoietic pro-
cess has been examined for CGRP. Treatment with capsaicin, a
potent neurotoxin to c fibers and activator of TRPV1, produced
a dramatic change in bone marrow hematopoiesis when mea-
sured by in vitro colony-forming assays suggesting that CGRP
has direct access to hematopoietic progenitors (Broome et al.,
2000). CGRP positive nerves have also been detected in the
cortical and vascular regions of lymph nodes. No evidence has
been obtained/presented for the presence of parasympathetic
nerves in lymph nodes or for the presence of the parasym-
pathetic neurotransmitter acetyl choline (Schafer et al., 1998).
However, non-neural sources for acetyl choline in lymphatic
organs have been identified (Rosas-Ballina et al., 2011) where it
is secreted by resident memory T cells in the spleen facilitating
vagal anti-inflammatory functions, therefore, playing part in the
vagal-immune pathways.
Many studies have demonstrated specific roles for CGRP and
other peptides, including substance P, in the generation of both
pro and anti-inflammatory immune responses. CGRP in par-
ticular has been the focus of many studies trying to unveil its
involvement in a range of inflammatory models and immune
conditions e.g., diabetes (Morrison et al., 2009), sepsis (DeWinter
et al., 2009), EAE (Mikami et al., 2012a) Crohn’s Disease (Smith
and Smid, 2005), and ulcerative colitis (Engel et al., 2012; Li
et al., 2013a). In rats, dextran sulfate sodium (DSS)-induced col-
itis worsened when treated with a CGRP antagonist suggesting a
protective role for CGRP in colitis (Engel et al., 2010).
Once released, CGRP plays multifunctional roles at different
sites by binding to its receptor calcitonin receptor like receptor
(CRLR) and its receptor activity-modifying protein 1 (RAMP1)
found on T and B lymphocytes (Mikami et al., 2012a,b),
macrophages (Fernandez et al., 2001), mast cells (Eftekhari et al.,
2013), and dendritic cells (Mikami et al., 2011) among others
(See Figure 1). CGRP is released from afferent fibers at the site
of stimulation, presenting a motor-like mode of action conducted
in parallel with afferent signaling to the DRG (Holzer and Maggi,
1998). However, it is well documented that cells of the immune
system, i.e., lymphocytes (Wang et al., 1999), monocytes (Bracci-
Laudiero et al., 2005), and macrophages (Linscheid et al., 2004;
Lee and Zhang, 2012) also synthesize CGRP. It is thought that
CGRP operates through the intracellularmolecules Protein kinase
C (PKC), PKA, and MAP kinase (MAPK) (Li et al., 2013b; Zhou
et al., 2013) particularly in the lung and uterus (Bai et al., 2012;
Mikami et al., 2013; Wong et al., 2013). In addition, CGRP influ-
ences NF-kappa-B activation and induction of cAMP suppressor
genes in immune cells, particularly dendritic cells (Harzenetter
et al., 2007) thereby regulating function.
CGRP REGULATES DENDRITIC CELL FUNCTIONS
Physiologically, CGRP was first found to be closely associated
with dendritic cells (DC) in the skin (Hosoi et al., 1993). This
study was the first to show a physical association between CGRP
and Langerhans cells (LC) in the human epidermis. Functionally,
it was one of the earliest publications to suggest an inhibitory
function for CGRP on LC antigen presentation. So far, the major-
ity of publications on the role of CGRP on DC suggest a predom-
inant anti-inflammatory rather than pro-inflammatory effect.
CGRP can modulate antigen presentation in DC (Mikami et al.,
2011), and inhibit lipopolysaccharide induction of co-stimulatory
signaling via the CD80 and CD28 receptors on dendritic cells
and monocytes thereby affecting the function of T cells (Fox
et al., 1997). Recently, Ganor et al. published a study on the role
of CGRP during HIV-1 infection. Initially, CGRP plasma levels
increased during the viral infection interfering with the induc-
tion of infection through LCs. CGRP inhibited the HIV-1 transfer
to T cells, dampening the viral replication by 6 fold (Ganor
et al., 2013). CGRP has also been shown to inhibit the migration
of LC to local lymph nodes in contact hypersensitivity models,
promoting Th2 type immunity in the process (Mikami et al.,
2011). In vitro lung (DC) maturation was inhibited with CGRP
(Rochlitzer et al., 2011). This correlated with a down regulation
of the CGRP receptor on these DC during airway inflammation
and these effects were reversed with the CGRP receptor antagonist
hCGRP8−37. CGRP continued to influence the antigen presenting
functions of DCs in the lungs even when DCs were pre-treated
with CGRP. DC phagocytosis and motility were modulated by
CGRP (Voedisch et al., 2012) suggesting an important role for
CGRP in maintaining immune integrity in the lungs via the con-
trol of DC functions. Similar to its effects on DCs in the skin
and lungs, CGRP also inhibits the function of bone marrow-
derived DCs. Through its receptor complex, CGRP inhibited the
production of (Tumor necrosis factor) TNFα and IL12 post-
LPS treatment highlighting its potent anti-inflammatory roles
(Tsujikawa et al., 2007). CGRP has additionally been identified
as a potent inhibitor of TLR induced inflammatory agents TNFα
and CCL4 (Harzenetter et al., 2007). CGRP has also been shown
to down regulate the surface expression of HLA-DR and CD86
on mature and immature human DC (Carucci et al., 2000), sug-
gesting a mechanism whereby CGRP may dampen DC-T cell
interaction.
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CGRP REGULATES LYMPHOCYTE DIFFERENTIATION AND
CYTOKINE PRODUCTION
CGRP shares aclose relationship with T cells. The interaction of
T cell with DCs and macrophages, both of which express the
CGRP receptor, is influenced by CGRP expression. (Ben-Horin
and Chowers, 2008; Rochlitzer et al., 2011; Jusek et al., 2012;
Holzmann, 2013). The capability of CGRP to regulate T cell func-
tion was proposed as early as 1988 (Umeda et al., 1988). In the last
decade, studies have demonstrated a Th2 polarized T cell response
after CGRP administration. Publications strongly suggest a TH2
preference by CGRP, through its influence on T cell differenti-
ation (Levite, 2000; Ding et al., 2008). In more than one study,
CGRP exposure to different DCs enhanced a TH2 type immunity
increasing IL4 production while decreasing the TH1-associated
cytokines interferon gamma (IFNγ) and IL2 (Wang et al., 1992;
Tokoyoda et al., 2004; Mikami et al., 2011). The observed sensiti-
zation, according to Tokoyoda et al., occurs through the CGRP
receptor activating cAMP/PKA pathways with the involvement
of the conventional CD3/CD28 co-stimulation signal in T cells
(Tokoyoda et al., 2004). CGRP has been shown to promote TH2
cytokine production in vitro and decrease TH1 cytokines (Levite,
1998, 2008). In 1998 and again in 2001, Levite et al., compared
antigen-driven and neuropeptide-driven cytokine secretion from
T helper cells (Levite, 1998; Levite and Chowers, 2001). They
found that in a controlled in vitro environment TH0, TH1, and
TH2 cells all produced “unconventional” cytokines respective
to their phenotype when exposed to neuropeptide, with TH1
secreting IL4, TH2 secreting IFNγ, and TH0 secreting both. This
suggests an ability to break the T helper line commitment and reg-
ulation of T cell functions. CGRP also up regulated IL9 and IL17
in both asthma and experimental autoimmune encephalomyeli-
tis (EAE) models (Mikami et al., 2012a, 2013). IL17 has been
attributed to a range of inflammatory functions and roles; how-
ever, its association with CGRP is still not understood. In an
EAE model, IL17 levels dropped in RAMP-1−/− mice and TH17
functions were suppressed, suggesting a role for CGRP in the
TH17 induced EAE (Mikami et al., 2012a). This has since been
corroborated in models of psoriasis where TH17 cells are the
dominant inflammatory phenotype (Ostrowski et al., 2011). In
contrast, the association of CGRP with CD4+CD25+Foxp3+
cells has also been studied in a model of EAE (Matsuda et al.,
2012). CGRP transfected DCs were able to increase differenti-
ation of CD4+CD25+Foxp3+ regulatory cells (Matsuda et al.,
2012). CGRP, is also produced by B lymphocytes in inflamma-
tory conditions under the influence of nerve growth factor (NGF)
(Bracci-Laudiero et al., 2002). The effect of CGRP on early B
cell differentiation has been examined using a pre-B cell line
population (70Z/3). CGRP inhibited the expression of surface
immunoglobulin in response to LPS (McGillis et al., 1993, 1995).
These studies suggest a crucial role for CGRP in early B cell dif-
ferentiation, a finding supported by later studies (Fernandez et al.,
2000; Schlomer et al., 2007).
CGRP AND IMMUNE MOTILITY, MIGRATION, AND
ADHESION
In 1992, CGRP was described as a neuropeptide with “chemotac-
tic” properties on human CD4 and CD8 T lymphocytes in the
skin, inducing T cell trafficking (Foster et al., 1992). Ever since, T
cells more than any other cell, have been themain targets for stud-
ies to understand the effect of CGRP on immune cell migration,
adhesion, and motility. CGRP plays a key role in T cell adhe-
sion to fibronectin (Levite, 1998; Levite et al., 1998) and beta
integrinmediated T cell migration. Somatostatin, CGRP and neu-
ropeptide Y all induced of freshly purified T cells to fibronectin
coated plates (Springer et al., 2003). Deletion of CGRP results in a
sustained decrease in leukocyte circulation and migration, high-
lighting its role in the bone marrow and in the mobilization of
immune cells (Broome and Miyan, 2000; Broome et al., 2000). In
the gut CGRP from c fibers stimulates T cell migration (Talme
et al., 2008). In vitro studies showed that in contrast to other
neuropeptides, CGRP can stimulate the migration of CD3 T cells
into collagen matrix (Talme et al., 2008), an effect inhibited with
CGRP receptor antagonist. In the absence of other immunolog-
ical signals extracellular K(+) plays a critical role in stimulating
T cell-integrin induced adhesion and migration. T cell voltage-
gated K channels (Kv1.3) are targeted by a number of molecules
to control T cell-integrin induced motility (Levite et al., 2000).
CGRP binding to T cells, through its receptor, opens the voltage-
gated K(+) channels, releasing K(+) from the intracellularmatrix
and activating β1 integrin. This facilitates T cell integrin-induced
function highlighting a critical role for CGRP in alternative path-
ways for T cell adhesion, migration and motility. The effect of
CGRP on macrophage and monocyte motility and chemotactic
activity has also been studied. In vitro, inoculated promastigotes
from cutaneous Leishmania major, demonstrated that CGRP, sub-
stance P, and somatstatin had regulatory effects on macrophage
chemotactic activity (Ahmed et al., 1998; Han et al., 2010). CGRP
was suggested to play an important role in human monocyte
adhesion and migration (Linscheid et al., 2004). Human neu-
trophils cultured in vitro with CGRP and LPS secreted high levels
of the chemokine IL8 (He et al., 2002), whilst CGRP has also been
proposed to stimulate eosinophil migration (Dunzendorfer et al.,
1998). CGRP increased the adhesion-related DC CD103+ ligand
epithelial cadherin (E-cadherin) expression in human bronchial
epithelial cells (Bai et al., 2012).
REGULATION OF OTHER IMMUNE CELLS
A wealth of literature can be found on the role of CGRP in
the inhibition of mast cell degranulation. Many studies have
reported mast cells and CGRP fibers “juxtaposed” in different
models (Bienenstock et al., 1987; Lee et al., 2013). Controlled
low dose capsaicin has been used to induce the release of CGRP
from sensory nerves (Demirbilek et al., 2004). It has been esti-
mated that nearly 60–70% of mast cells in the jejunum of rats
infected withNippostrongylus brasiliensis are juxtaposed to CGRP
containing nerve fibers suggesting a role for this association
in the immune response to this infection at least (Bienenstock
et al., 1987; Dimitriadou et al., 1994) but no doubt in others
also. Moreover, desensitization or deletion of c fibers with high
doses of capsaicin severely impaired mast cell recruitment during
Schistosoma mansoni infection in mice (De Jonge et al., 2003; Van
Nassauw et al., 2007). Similarly, CGRP inhibitedmast cell degran-
ulation in a model of cerebral ischemia in rats (Feng et al., 2010)
and in response to anti/IgE treatments, in comparison to other
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neuropeptides, in an in vitro assay with primary humanmast cells
(Kulka et al., 2008).
CGRP receptor is also expressed on human monocytes
(Caviedes-Bucheli et al., 2008). Under the influence of NGF,
CGRP has been shown to regulate the expression of MHCII,
CD86 and the production of IL10 in human monocytes in vitro
(Bracci-Laudiero et al., 2005). However, it seems that the role
of CGRP in monocytes/macrophages seems to be less direct
than that seen in other immune cells. CGRP is synthesized by
monocytes/macrophages and can regulate immune functions of
these cells (Ma et al., 2010). For instance CGRP can regulate
CD11b expression after LPS exposure in humanmacrophages and
neutrophils promoting anti-inflammatory functions (Monneret
et al., 2003). Recently, macrophages have been studied in the con-
text of pain induction and their involvement in pain pathways
during inflammation (Hasegawa-Moriyama et al., 2013; Isami
et al., 2013; Taves et al., 2013). In various studies, CGRP treat-
ment increased IL10 from both peritoneal and bone marrow
derived macrophages in response to LPS (Jusek et al., 2012).
CGRP receptor absence resulted in the influx of neutrophils and
inflammatory mediators into the peritoneal cavity (Jusek et al.,
2012). CGRP was able to regulate the synthesis of triggering
receptor expressed on myeloid cells-1 (TERM-1) in LPS-induced
macrophages (Li et al., 2010). This effect was absent without
LPS. However, the main contribution of CGRP to macrophage
function is likely to incorporate its newly found links to the pro-
inflammatory cytokine TNFα. This is the main cytokine released
by macrophages in response to pathological challenges.
CGRP AND TNFα: A NEW CHAPTER
TNFα and CGRP are two important molecules that demon-
strate a key bi-directional influence between the nervous and
immune systems. TNFα functions through its receptors TNFRI
and TNFRII. These receptors are found on glial cells in the
spinal cord which, when activated, release prostaglandins, acti-
vating in turn nociceptive neurons and eliciting a pain response.
Thus, the involvement of TNFα in peripheral and central pain
is no longer a matter of doubt (Saito et al., 2010; Zhang et al.,
2010a; Bressan et al., 2011; Gim et al., 2011; Teodorczyk-Injeyan
et al., 2011). TNFα has been associated with the enhancement of
trigeminal neuronal sensitivity to capsaicin in rats (Khan et al.,
2008); exposure to TNFα for 5min doubles the sensitivity of
fura-loaded trigeminal neurons to capsaicin via TRPV1. Both
TNFα receptors were present on capsaicin-sensitive trigeminal
neurons co-expressed with TRPV1 (Khan et al., 2008). The pres-
ence of the TNFα receptors next to TRPV1 suggests that TNFα
sensitizes TRPV1 positive neurons through its receptors. TNFRI
plays a role in sensitizing tetrodotoxin (TTX)-resistant sodium
channels (Jin and Gereau, 2006). It is likely that TNFRI has addi-
tional functions in immediate hyperalgesia and nociception to
damage (Sommer et al., 1998), whileTNFRII is thought to have
a role in nociception in persistent/chronic injurious conditions
(Constantin et al., 2008; Schafers et al., 2008). A recent study
has also linked TNFα to meningeal nociception (Zhang et al.,
2010b), where it was suggested that TNFα functioned through
TNFRI &TNFRII on nociceptive neurons and was associated with
the “throbbing” sensation significant in migraines. Interestingly,
neutralizing antibodies against TNFRI modulated thermal and
mechanical hyperalgesia while antibodies against TNFRII had
no affect (Sommer et al., 1998). Electrophysiological techniques
showed that the local application of TNFα at the peripheral
level of sensory neurons excites TRPV1 bearing sensory c fibers
suggesting a specific role for TNFα in nociception (Sorkin and
Doom, 2000). Additionally, TNFα increased CGRP release from
sensitized capsaicin sensitive neurons when given 5min prior to
capsaicin treatment in comparison to vehicle treated rats (Khan
et al., 2008). During LPS endotoxin treatment the increase in
CGRP release was attributed to TNFα sensitizing afferent neurons
in the presence of the prostaglandin sub types, prostanoids (Hua
et al., 1996). These studies suggest that the nociceptive functions
of TNFα occur via the specific capsaicin receptor TRPV1.
The activation of the specific capsaicin receptor TRPV1 located
on c fibers or capsaicin sensitive neurons results in the release
of sensory neuropeptides i.e., CGRP and SP (Helliwell et al.,
1998; Bhave et al., 2002; Shepherd et al., 2005a; Ren et al.,
2011). Additionally, reduction in CGRP tissue expression lev-
els was seen in the dorsal root ganglia of rats injected with
Entanercept (anti-TNFα treatment) (Horii et al., 2010). In both
rats and humans with rheumatoid arthritis, CGRP and SP levels
were reduced by 50% in the serum after treating with Etanercept
(Origuchi et al., 2010). By contrast, TRPV1 activation via cap-
saicin and SA13353 (capsaicin analog) attenuated LPS-induced
TNFα release in serum, and this effect was partially inhibited with
CGRP antagonist treatment and in TRPV1−/− or sensory dener-
vated mice (Tsuji et al., 2009) suggesting a regulatory function for
CGRP on TNFα i.e., CGRP is able to downregulate TNFα in vivo.
Both small doses (1mg/kg) and large doses (150mg/kg) of the
TRPV1 agonist capsaicin have been found to downregulate serum
levels of a range of pro-inflammatory cytokines including TNFα
(Demirbilek et al., 2004), and the effects of capsaicin are attenu-
ated in the presence of the antagonist for either TRPV1 or CGRP
(Peng and Li, 2009).
In Toll-like receptor stimulated dendritic cells, CGRP causes
a rapid up-regulation of inducible cAMP early repressor (ICER)
which competes with ATF-2 for binding at the Tnfα promoter
gene preventing gene expression of TNFα (Altmayr et al., 2010).
In experiments using a non-irritating capsaicin analog (Vanillyl
nonanoate) to examine the protective role capsaicin has on gas-
tric mucosa (Luo et al., 2011), increased release of CGRP via
TRPV1 activation had the ability to attenuate TNFα release in
the serum post ethanol treatment. Blocking CGRP release from
TRPV1 caused an increase in TNFα serum levels and increased
gastric mucosal damage (Luo et al., 2011). Taken together all the
findings suggest the presence of a TNFα-CGRP regulatory “loop”
that is mediated via TRPV1 bearing sensory neurons releasing
CGRP and/or through intracellular transcriptional interference of
TNFα expression by immune cells.
CONCLUSION
CGRP has critical and wide-ranging control functions in various
body systems and is particularly critical to normal hemopoi-
etic and immune functions. CGRP-containing c nerve fibers are
found everywhere in the body and are associated, in many loca-
tions, with specific immune cells including dendritic cells, mast
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cells and T cells. It appears to be the key mediator of neuro-
immune communication with the c fibers acting as both sensory
pathways, informing the nervous system of peripheral challenges,
and as a local controller of immune functions. Knocking out this
neural system results in major down-regulation of bone mar-
row hemopoietic output supporting a role for these nerve fibers
in sensory feedback to immune control centers, already identi-
fied in the central nervous system by Denes et al. (2005). It is
therefore becoming increasingly clear that this intimate connec-
tion between a specific subset of specialist sensory neurons and
immune cells throughout the body, together with the connec-
tions to the brain and host defense control centers, is vital to
the integrated, coordinated host defense response to any periph-
eral challenge. Moreover, it is clear that immune mediators,
specifically pro-inflammatory cytokines IL-1a and TNFα, have
direct effects on brain activity and whole body responses through
the stimulation of specific circuits involved in so-called sickness
behaviors (Dantzer and Kelley, 2007) that channel energy into
host defense at the cost of social and other activities. A more com-
plete understanding of this neural-immune interaction is vital
to uncover key avenues for intervention to override abnormal
functions and improve normal functions.
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